{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:16:16Z","timestamp":1790248576485,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81302628"],"award-info":[{"award-number":["81302628"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Six Peaks of Talent","award":["2014-SWYY-044"],"award-info":[{"award-number":["2014-SWYY-044"]}]},{"DOI":"10.13039\/501100002857","name":"China Pharmaceutical University","doi-asserted-by":"publisher","award":["SKLNMKF201415"],"award-info":[{"award-number":["SKLNMKF201415"]}],"id":[{"id":"10.13039\/501100002857","id-type":"DOI","asserted-by":"publisher"}]},{"name":"China and Jiangsu Province Postdoctoral Science Foundation","award":["2016M590488"],"award-info":[{"award-number":["2016M590488"]}]},{"name":"China and Jiangsu Province Postdoctoral Science Foundation","award":["1601136B"],"award-info":[{"award-number":["1601136B"]}]},{"name":"Jiangsu Government Scholarship","award":["JS-2014-212"],"award-info":[{"award-number":["JS-2014-212"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["CA177584"],"award-info":[{"award-number":["CA177584"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ejmech.2018.05.025","type":"journal-article","created":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T12:34:26Z","timestamp":1526646866000},"page":"199-209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Development of novel amino-quinoline-5,8-dione derivatives as NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibitors with potent antiproliferative activities"],"prefix":"10.1016","volume":"154","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3373-011X","authenticated-orcid":false,"given":"Yong","family":"Ling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Xing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ning","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Ling","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Morris-Natschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Chuan","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6562-0070","authenticated-orcid":false,"given":"Kuo-Hsiung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.05.025_bib1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1477-3163-5-14","article-title":"Reactive oxygen species: role in the development of cancer and various chronic conditions","volume":"5","author":"Waris","year":"2006","journal-title":"J.\u00a0Carcinog."},{"key":"10.1016\/j.ejmech.2018.05.025_bib2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10555-006-9037-8","article-title":"The signaling mechanism of ROS in tumor progression","volume":"25","author":"Wu","year":"2006","journal-title":"Canc. Metastasis Rev."},{"key":"10.1016\/j.ejmech.2018.05.025_bib3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejphar.2015.12.026","article-title":"ZT-25, a new vacuolar H+-ATPase inhibitor, induces apoptosis and protective autophagy through ROS generation in HepG2 cells","volume":"771","author":"Lu","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.05.025_bib4","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1042\/BSR20130066","article-title":"How does the metabolism of tumour cells differ from that of normal cells","volume":"33","author":"Amoedo","year":"2013","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ejmech.2018.05.025_bib5","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.biopha.2017.11.117","article-title":"Stachydrine ameliorates carbon tetrachloride-induced hepatic fibrosis by inhibiting inflammation, oxidative stress and regulating MMPs\/TIMPs system in rats","volume":"97","author":"Zhang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2018.05.025_bib6","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrd4002","article-title":"Modulation of oxidative stress as an anticancer strategy","volume":"12","author":"Gorrini","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.05.025_bib7","first-page":"88","article-title":"Synthesis, cytotoxicity and pro-apoptosis activity of isoquinoline quinones","volume":"87","author":"Ni","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2018.05.025_bib8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.toxlet.2015.08.011","article-title":"Pyrroloquinoline quinone-conferred neuroprotection in rotenone models of Parkinson's disease","volume":"238","author":"Qin","year":"2015","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejmech.2018.05.025_bib9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ctrv.2004.01.002","article-title":"Exploiting tumor hypoxia in cancer treatment","volume":"30","author":"Danson","year":"2004","journal-title":"Canc. Treat Rev."},{"key":"10.1016\/j.ejmech.2018.05.025_bib10","first-page":"4752","article-title":"Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin C","volume":"52","author":"Malkinson","year":"1992","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2018.05.025_bib11","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/oxfordjournals.jbchem.a124470","article-title":"One- and two-electron reduction of quinones by rat liver subcellular fractions","volume":"115","author":"Nakamura","year":"1994","journal-title":"J\u00a0Biochens"},{"key":"10.1016\/j.ejmech.2018.05.025_bib12","first-page":"1420","article-title":"Subcellular localization of NAD(P)H: quinone oxidoreductase 1 in human cancer","volume":"62","author":"Winski","year":"2002","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2018.05.025_bib13","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1093\/carcin\/14.12.2441","article-title":"Elevation of serum Phase II enzymes by anticarcinogenic enzyme inducers: markers for a cemoprotected state?","volume":"14","author":"Prochaska","year":"1993","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejmech.2018.05.025_bib14","first-page":"1338","article-title":"Increased NAD(P)H:(quinone-acceptor)oxidoreductase activity is associated with density-dependent growth inhibition of normal but not transformed cells","volume":"53","author":"Schlager","year":"1993","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2018.05.025_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2016.06.019","article-title":"Synthesis and antitumor activity of selenium-containing quinone-based triazoles possessing two redox centres, and their mechanistic insights","volume":"122","author":"da Cruz","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.025_bib16","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1021\/jm301689x","article-title":"Synthesis of new quinolinequinone derivatives and preliminary exploration of their cytotoxic properties","volume":"56","author":"Keyari","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.025_bib17","doi-asserted-by":"crossref","first-page":"7733","DOI":"10.1021\/jm050758z","article-title":"Novel lavendamycin analogues as antitumor agents: synthesis, in\u00a0vitro cytotoxicity, structure-metabolism, and computational molecular modeling studies with NAD(P)H: quinone Oxidoreductase 1","volume":"48","author":"Hassani","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.025_bib18","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF02975181","article-title":"Effects of 6-arylamino-5,8-quinolinediones and 6-chloro-7-arylamino-5,8-isoquinolinediones on NAD(P)H: quinone oxidoreductase (NQO1) activity and their cytotoxic potential","volume":"24","author":"Ryu","year":"2001","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejmech.2018.05.025_bib19","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.bmc.2004.01.021","article-title":"Novel quinolinequinone antitumor agents: structure-metabolism studies with NAD(P)-H:quinone oxidoreductase (NQO1)","volume":"12","author":"Fryatt","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.025_bib20","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1021\/jm010884c","article-title":"Indolequinone antitumor agents: correlation between quinone structure and rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase. Part 2","volume":"44","author":"Swann","year":"2001","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.025_bib21","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1021\/jm701066a","article-title":"Lavendamycin antitumor agents: structure-based design, synthesis, and NAD(P)H:quinone oxidoreductase 1 (NQO1) model validation with molecular docking and biological studies","volume":"51","author":"Hassani","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.025_bib22","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/j.bmc.2010.01.037","article-title":"Synthesis, metabolism and in\u00a0vitro cytotoxicity studies on novel lavendamycin antitumor agents","volume":"18","author":"Cai","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.025_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejmech.2017.02.004","article-title":"Discovery of quinone-directed antitumor agents selectively bioactivated by NQO1 over CPR with improved safety profile","volume":"129","author":"Bian","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.025_bib24","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.ejmech.2016.12.031","article-title":"Alkynyloxy derivatives of 5,8-quinolinedione: synthesis, in\u00a0vitro cytotoxicity studies and computational molecular modeling with NAD(P)H: quinone oxidoreductase 1","volume":"126","author":"Kadela-Tomanek","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.05.025_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0304-4165(96)00124-9","article-title":"The structure of streptonigrin semiquinone in solution","volume":"1335","author":"Soedjak","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2018.05.025_bib26","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1016\/S0040-4039(00)97755-4","article-title":"Oxidation of phenols to quinones by bis(trifluoroacetoxy)iodobenzene","volume":"31","author":"Barret","year":"1990","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2018.05.025_bib27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1021\/jo9815397","article-title":"A\u00a0biomimetic approach to the discorhabdin alkaloids: total syntheses of discorhabdins C and E and dethiadiscorhabdin D","volume":"64","author":"Aubart","year":"1999","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2018.05.025_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nchembio.1712","article-title":"Targeting mitochondria metabolism for cancer therapy","volume":"11","author":"Weinberg","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2018.05.025_bib29","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1007\/s00044-012-0245-1","article-title":"Synthesis and bioevaluation of novel arylnaphthalene lignans as anticancer agents","volume":"22","author":"Yu","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2018.05.025_bib30","article-title":"Novel ezrin inhibitors and methods of making and using","author":"Brown","year":"2012","journal-title":"PCT Int. Appl"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418304355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418304355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T12:04:44Z","timestamp":1534853084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418304355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":30,"alternative-id":["S0223523418304355"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.05.025","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of novel amino-quinoline-5,8-dione derivatives as NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibitors with potent antiproliferative activities","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}